Recent Finacing
Recent Raise
Applied StemCell develops gene-editing platforms and therapeutics using proprietary TARGATT and CRISPR/Cas9, produces tools and animal/cell models, and advances a pipeline targeting monogenic blood and high-penetrance diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
